age
individu
immunolog
character
loss
immunolog
protect
respons
autoimmun
occur
increas
incid
review
studi
specif
agerel
chang
b
cell
gener
activ
mainten
well
characterist
b
cell
respons
antibodi
level
age
relat
cell
factor
interwoven
b
cell
biolog
process
elderli
fewer
new
b
cell
gener
b
cell
respons
antigen
impair
smaller
fewer
germin
center
form
within
immun
respons
particip
less
potent
cell
follicular
dendrit
cell
lead
product
reduc
often
insuffici
plasma
cell
number
recal
respons
elderli
appear
limit
cell
prolif
capac
henc
vaccin
respons
often
insuffici
autoantibodi
product
emerg
elderli
total
b
cell
appear
less
affect
age
compar
cell
recent
new
concept
develop
counteract
immunosenesc
beyond
activ
vaccin
compris
gener
specif
monoclon
antibodi
passiv
vaccin
immun
rejuven
immunoabl
follow
autolog
stem
cell
transplant
modul
lifestyl
briefli
b
cell
gener
hematopoiet
stem
cell
hsc
bone
marrow
bm
matur
becom
b
cell
releas
peripheri
matur
bm
b
cell
rearrang
immunoglobulin
gene
encod
b
cell
receptor
antibodi
molecul
thu
determin
antigen
specif
individu
b
cell
gene
rearrang
activ
altern
cell
prolifer
highli
divers
repertoir
b
cell
gener
carri
individu
specif
uniqu
b
cell
receptor
bcr
b
cell
activ
bind
antigen
bcr
follow
prolifer
differenti
either
plasmablast
secret
larg
amount
antibodi
specif
bcr
memori
b
cell
remain
peripheri
acut
immun
respons
ceas
memori
b
cell
activ
antigen
differenti
plasmablast
memori
b
cell
enhanc
potenc
respons
recurr
antigen
challeng
somat
hypermut
shm
class
switch
recombin
csr
select
antigen
affin
characterist
germin
center
reaction
memori
b
cell
respons
engag
cell
help
may
occur
spleen
lymph
node
mucosaassoci
lymphoid
tissu
termin
differenti
antibodysecret
plasma
cell
memori
b
cell
persist
year
decad
one
bodi
yet
fulli
defin
contribut
selfrenew
longev
cell
wherea
memori
b
cell
resid
secondari
lymphoid
organ
blood
plasma
cell
resid
bm
almost
b
cell
differenti
stage
properti
function
agerel
chang
detect
mainli
associ
reduc
immun
function
protect
eg
cell
appar
greatli
affect
age
b
cell
work
directli
indirectli
question
inher
senesc
b
cell
contribut
inher
extrins
factor
senesc
b
cell
respons
remain
elucid
gener
discuss
whether
agerel
immun
phenomena
reflect
caus
reach
great
age
whether
immunosenesc
process
remodel
immun
system
indic
immunodefici
regard
healthi
centenarian
often
show
differ
pattern
chang
compar
popul
consider
impact
frailti
inconsist
result
conclus
publish
research
agerel
chang
b
cell
function
includ
critic
point
henc
difficult
draw
clear
pictur
age
b
cell
respons
least
variat
origin
heterogen
human
subject
analyz
regard
genet
background
lifestyl
hidden
overt
comorbid
gener
frailti
end
senieur
protocol
establish
contain
donor
admiss
criteria
immunogerontolog
studi
numer
studi
document
age
individu
highli
increas
risk
die
infecti
diseas
death
caus
infect
old
individu
usa
influenzaassoci
death
respiratori
syncyti
viru
rsv
associ
death
occur
among
peopl
year
age
sever
acut
respiratori
syndrom
sar
outbreak
patient
age
strongli
associ
outcom
ie
fatal
rate
time
higher
peopl
year
age
compar
peopl
year
age
time
age
individu
respond
less
frequent
less
effici
common
vaccin
tetanu
hepat
b
pneumococc
polysaccharid
influenza
includ
mucos
vaccin
failur
respond
appropri
influenza
vaccin
appear
associ
specif
b
cell
properti
low
blood
igd
b
cell
number
reduc
vitro
lymphocyt
respons
pokewe
mitogen
least
age
individu
higher
igg
titer
cytomegaloviru
young
elderli
risk
develop
bcellderiv
malign
autoimmun
increas
advanc
age
type
diseas
treatment
irradi
surgic
tissu
remov
immunosuppress
cytostat
may
affect
b
cell
respons
addit
intrins
immunosenesc
b
cell
subject
malign
transform
known
differenti
stage
result
varieti
lymphoma
b
cell
nonhodgkin
lymphoma
reedsternberg
cell
lead
hodgkin
diseas
monoclon
plasma
cell
expans
multipl
myeloma
besid
lifethreaten
primari
malign
diseas
excess
clonal
b
cell
may
addit
impair
immun
respons
compet
normal
b
cell
surviv
cell
migrat
factor
habitat
activ
signal
eg
germin
center
lymphoid
organ
clonal
expans
b
cell
also
disturb
destroy
microarchitectur
lymphoid
tissu
thu
impair
process
involv
b
cell
respect
site
eg
b
lymphopoiesi
plasma
cell
resid
bm
follicl
organ
within
spleen
lymph
node
exampl
approxim
patient
monoclon
gammopathi
undetermin
signific
show
reduct
uninvolv
antibodi
level
b
cell
repres
major
target
natur
reservoir
epsteinbarr
viru
ebv
human
infect
ebv
ebv
individu
viruscontain
b
cell
rare
b
cell
malign
origin
germin
center
reaction
associ
infect
ebv
ie
burkitt
lymphoma
hodgkin
lymphoma
coher
ebvassoci
b
cell
tumor
express
ebvencod
protein
like
ebv
nuclear
antigen
ebna
latent
membran
protein
lmp
combin
thereof
autoimmun
per
se
associ
suppress
respons
antigen
challeng
howev
wide
use
immunosuppress
drug
steroid
cyclophosphamid
tnfa
block
antibodi
target
lymphocyt
dampen
b
cell
respons
associ
increas
suscept
infect
success
b
cell
deplet
underlin
key
role
b
cell
immun
respons
autolog
antigen
patient
treat
b
cell
deplet
therapi
rituximab
use
autoimmun
lymphoma
treatment
develop
suffici
antibodi
titer
vaccin
therapi
remain
wide
protect
therapi
previous
establish
plasma
cell
affect
respect
antibodi
titer
slightli
affect
rituximab
treatment
autoimmun
addit
increas
risk
malign
b
cell
transform
reflect
eg
margin
zone
lymphoma
cell
often
carri
rheumatoid
factor
rf
specif
immunosenesc
impact
properti
b
cell
b
cell
respons
b
cell
respons
intrins
chang
b
lineag
cell
importantli
influenc
multipl
extrins
factor
cytokin
interact
support
cell
structur
old
age
b
cell
gener
differenti
bm
impair
qualiti
quantiti
tenfold
higher
frequenc
clonabl
progenitor
bcell
prob
cell
precursor
b
cell
preb
cell
detect
mice
shortli
birth
compar
mice
age
crucial
step
initi
b
cell
develop
express
recombinas
allow
v
j
recombin
prob
cell
allow
becom
preb
cell
recombin
activ
gene
rag
protein
messeng
rna
mrna
level
total
bm
reflect
activ
earli
b
cell
differenti
increas
birth
month
age
remain
detect
severli
reduc
latest
month
inde
bm
old
mice
contain
compar
number
prob
cell
fewer
half
number
preb
cell
compar
young
mice
cyclophosphamideinduc
lymphopenia
model
old
mice
splenic
b
cell
repres
peripher
b
cell
present
one
third
number
young
mice
compar
restrict
repertoir
suggest
increas
apoptosi
preb
cell
would
account
reduc
number
bm
old
mice
involv
reduc
express
antiapoptot
protein
bclxl
although
prob
cell
number
mrna
amount
within
fraction
normal
age
mice
express
less
show
less
v
j
recombinas
activ
gave
rise
fewer
preb
cell
vivo
vitro
j
v
dj
recombin
diminish
old
mice
stage
earli
late
prob
cell
defect
prebcr
express
suggest
contribut
preb
cell
apoptosi
inde
surrog
light
chain
express
decreas
preb
cell
senesc
mice
associ
decreas
express
b
cell
express
igh
igl
transgen
introduc
need
undergo
rearrang
number
transgen
b
cell
normal
wherea
endogen
b
cell
number
natur
rearrang
igl
igh
gene
reduc
age
mice
earli
b
cell
develop
appear
depend
regul
thymic
activ
athym
nude
mice
old
euthym
mice
show
decreas
number
bm
preb
cell
fewer
express
protein
declin
express
age
follow
similar
kinet
thymic
activ
involut
coher
thymu
engraft
induc
b
cell
develop
xlink
immunedefici
mice
wherea
thymu
cell
age
anim
abl
reconstitut
b
cell
matur
bm
inject
supernat
activ
cell
restor
express
preb
cell
number
athym
mice
vivo
defect
age
microenviron
b
lymphopoiesi
suggest
contribut
reduc
b
cell
gener
therefor
might
influenc
agerel
chang
bone
structur
eg
osteoporosi
stromal
cell
senesc
inde
bm
stromal
cell
rescu
young
old
b
cell
precursor
dexamethasoneinduc
apoptosi
insulinlik
growth
factor
counteract
apoptosi
bax
bclx
l
human
bm
b
cell
subset
eg
preb
cell
prob
cell
reflect
matur
b
cell
detect
compar
frequenc
throughout
age
year
maintain
prolif
capac
capac
b
cell
maintain
whole
popul
cell
replic
could
limit
length
telomer
human
germin
center
b
cell
carri
longer
telomer
rest
b
cell
express
telomeras
enzym
extend
telomer
restrict
fragment
upon
vitro
vivo
activ
henc
way
strength
b
cell
activ
might
influenc
b
cell
respons
determin
telomer
lengthen
age
telomer
peripher
blood
memori
b
cell
shorten
induc
telomeras
express
remain
unaffect
age
surviv
individu
b
cell
depend
receptor
signal
molecul
express
b
cell
bcr
phospholipas
cg
ebvinfect
b
cell
viral
encod
protein
substitut
function
survivalpromot
b
cell
surfac
receptor
wherea
tonic
bcr
signal
replac
express
simul
b
cell
surviv
importantli
depend
factor
produc
b
cell
microenviron
b
cell
activ
factor
baff
proliferationinduc
ligand
april
interleukin
allow
variou
senescenceassoci
phenomena
impact
b
cell
surviv
matur
b
cell
appear
selfsuffici
intrins
limit
live
organ
joint
effect
cell
surviv
homeostat
prolifer
consist
function
b
cell
could
recov
month
transfer
scid
mice
util
antibodi
respons
halflif
peripher
matur
b
cell
old
mice
increas
decreas
turnov
reduc
level
newli
gener
b
cell
detect
peripheri
demonstr
use
vivo
label
experi
old
mice
number
immatur
splenic
b
cell
found
reduc
fourfold
concurr
reduct
number
bm
surfac
igd
surfac
igm
inthigh
b
cell
least
matur
surfac
igd
surfac
igm
low
b
cell
week
label
matur
transit
b
cell
newli
made
old
mice
compar
young
mice
immatur
b
cell
product
rate
differ
old
young
mice
studi
defect
replenish
peripher
compart
rather
impair
b
lymphopoiesi
reason
respons
reduc
peripher
count
immatur
b
cell
age
mice
summari
matur
peripher
b
cell
compart
semm
stabli
persist
age
mice
shown
independ
age
rel
littl
known
human
b
cell
turnov
circul
b
cell
old
individu
less
young
individu
suscept
apoptosi
term
annexin
v
bind
day
peripher
blood
mononuclear
cell
cultur
circul
b
cell
turnov
rate
assess
incorpor
heavi
glucos
slightli
decreas
age
differ
b
cell
approxim
cell
divid
day
memori
b
cell
approxim
cell
divid
day
memori
b
cell
longliv
plasma
cell
constitut
immunolog
b
cell
memori
longtem
persist
absenc
antigen
demonstr
directli
challeng
memori
b
cell
question
mean
provid
humor
memori
plasma
cell
accumul
evid
distinct
regul
memori
b
cell
compart
humor
memori
provid
plasma
cell
reflect
persist
antibodi
product
absenc
memori
b
cell
maintain
bodi
differ
site
distinct
mechan
memori
b
cell
resid
lymphoid
tissu
spleen
tonsil
lymph
node
mucosaassoci
lymphoid
tissu
blood
depend
presenc
spleen
reflect
gradual
disappear
peripher
blood
splenectomi
human
concurr
increas
suscept
microbi
infect
low
frequenc
circul
memori
b
cell
prolifer
allow
mainten
whole
popul
singl
specif
contrast
matur
plasma
cell
resid
mainli
bm
surviv
secret
antibodi
potenti
decad
old
mice
human
reflect
persist
antigenspecif
antibodi
titer
human
blood
serum
adult
age
year
longliv
plasma
cell
maintain
yet
incomplet
explor
henc
hypothet
surviv
nich
compris
e
g
stromal
cell
product
well
extracellular
matrix
compon
fibronectin
hyaluronan
bm
microenviron
becom
less
potent
support
b
cell
develop
age
senesc
stromal
cell
exhibit
limit
surviv
function
might
implic
role
senesc
bm
microenviron
reduc
plasmablast
recruit
plasma
cell
surviv
similarli
shown
mice
yet
adult
immun
capabl
young
age
bm
stromal
cell
larg
fail
support
plasma
cell
surviv
persist
antibodi
memori
thereaft
week
age
approxim
plasma
cell
may
becom
longliv
demonstr
lupuspron
new
zealand
blacknew
zealand
white
mice
hoyer
bf
voigt
c
mumtaz
im
pann
moser
kv
eilat
manz
ra
radbrucha
hiep
f
manuscript
submit
allow
fill
surviv
nich
develop
respect
antibodi
repertoir
increas
blood
serum
immunoglobulin
concentr
adult
plateau
valu
plasma
cell
settl
nich
earli
life
appar
provid
persist
antibodi
level
illustr
autoantibodi
aris
patient
system
lupu
erythematosu
sle
approxim
year
manifestationdiagnosi
diseas
eg
antiro
antila
especi
hard
erad
therapi
adulthood
serum
immunoglobulin
level
remain
overal
constant
plasma
cell
nich
satur
consist
approxim
splenic
plasma
cell
form
within
month
may
becom
longliv
old
mice
compar
young
mice
within
time
period
hoyer
voigt
radbruch
hiep
et
al
unpublish
result
henc
newli
gener
plasma
cell
induc
within
new
system
immun
respons
compet
resid
plasma
cell
habitat
newli
acquir
longlast
humor
immun
thu
reflect
success
competit
accompani
stoichiometr
loss
resid
polyclon
plasma
cell
regard
competit
subsequ
mobil
resid
plasma
cell
might
contribut
slow
decreas
antigenspecif
titer
antigen
see
later
mutual
nonexclus
mechan
maintain
antigenspecif
antibodi
titer
may
exist
ie
homeostat
prolifer
matur
plasma
cell
continu
de
novo
gener
plasma
cell
memori
b
cell
activ
bystand
mode
persist
antigen
bm
plasma
cell
adult
human
perform
cell
divis
term
express
therefor
homeostat
prolifer
mean
maintain
plasma
cell
popul
long
term
old
age
exclud
given
homeostat
plasma
cell
prolifer
exist
chang
bm
microenviron
might
impact
antibodi
titer
function
age
continu
gener
plasma
cell
memori
b
cell
age
could
impact
b
cell
abil
activ
prolifer
discuss
section
chapter
number
frequenc
total
b
cell
peripher
blood
found
reduc
age
detect
reduc
b
cell
count
blood
cluster
low
cell
vitro
cell
respons
predict
higher
mortal
suscept
infect
studi
observ
chang
composit
peripher
blood
b
cell
memori
b
cell
b
cell
depend
age
birth
adulthood
proport
memori
b
cell
among
total
circul
b
cell
increas
approxim
cord
blood
approxim
year
age
peripher
blood
adult
level
approxim
proport
increas
age
individu
gener
larger
variat
peripher
b
cell
composit
detect
old
human
howev
confirm
increas
proport
memori
b
cell
age
decreas
proport
memori
b
cell
age
also
observ
remain
unclear
degre
b
lymphopoiesi
b
cell
output
peripheri
affect
age
human
see
earlier
antigenexperienc
memori
b
cell
recircul
resid
lymphoid
tissu
spleen
mucos
tissu
remain
unclear
whether
b
cell
count
peripher
blood
reflect
b
cell
memori
whole
analys
impact
age
b
cell
repertoir
often
restrict
specif
ig
gene
famili
cell
subset
limit
specif
experiment
condit
exampl
analys
perform
total
white
blood
cell
allow
consider
contribut
memori
versu
versu
transit
b
cell
total
blood
b
cell
analyz
thu
introduc
consider
bia
henc
inconsist
observ
made
includ
increas
reduct
stabil
repertoir
agerel
decreas
repertoir
divers
ig
v
h
complementaritydetermin
region
cdr
circul
b
cell
describ
character
clonal
b
cell
expans
vivo
individu
year
age
splenic
b
cell
age
mice
reflect
restrict
bcr
repertoir
show
smaller
restrict
number
sequenc
give
rise
b
cell
clone
age
individu
loss
divers
correl
poorer
health
statu
prospect
mortal
peripher
blood
b
cell
v
h
famili
util
bias
toward
express
v
h
v
h
v
h
v
h
v
h
elderli
individu
wherea
v
h
found
sole
young
individu
v
h
express
elderli
tonsillar
b
cell
v
h
famili
show
agedepend
chang
repertoir
divers
circul
b
cell
repertoir
adult
individu
analyz
twice
year
apart
four
five
donor
appar
chang
v
h
famili
distribut
detect
human
splenic
germin
center
accumul
antigenselect
b
cell
age
reflect
higher
mutat
frequenc
rs
ratio
detect
within
cdr
opposit
effect
observ
analyz
germin
center
b
cell
young
versu
old
peyer
patch
overal
ig
gene
usag
exhibit
chang
age
mice
particularli
influenc
age
cell
engag
antigenspecif
immun
respons
see
later
analys
mucos
b
cell
respons
mainli
point
reduc
function
age
individu
conflict
data
suggest
normal
mucos
b
cell
respons
old
age
oral
cholera
toxin
challeng
induc
normal
plasma
cell
number
spleen
mesenter
lymph
node
regular
humor
immun
respons
old
mice
wherea
igg
iga
plasma
cell
lamina
propria
iga
plasma
cell
peyer
patch
detect
reduc
level
old
anim
antigen
appli
peritoneum
stomach
specif
plasma
cell
format
declin
age
spleen
peripher
lymph
node
mesenter
bronchial
mediastin
lymph
node
shown
mucos
b
cell
respons
normal
mice
becom
strongli
impair
earli
year
birth
reflect
erad
humor
secretori
antibodi
respons
cholera
toxin
ovalbumin
adjuv
includ
gener
specif
secretori
iga
analys
perform
mice
littl
impair
observ
agerel
impair
secretori
antibodi
respons
demonstr
senesc
rat
show
reduc
iga
plasma
cell
number
intestin
lamina
propria
concurr
iga
b
cell
peyer
patch
accumul
doubl
number
young
anim
fewer
b
integrin
iga
plasmablast
detect
blood
circul
old
rat
addit
show
diminish
densiti
bloodvesselexpress
mucos
addressin
cell
adhes
molecul
ligand
b
integrin
lamina
propria
impair
iga
plasmablast
migrat
conclud
effect
immunosenesc
investig
unimmun
mice
age
month
show
agerel
differ
frequenc
phenotyp
germin
center
b
cell
resid
peyer
patch
among
germin
center
b
cell
iga
b
cell
frequent
concurr
reduc
frequenc
igm
b
cell
turn
show
increas
mutat
frequenc
within
sequenc
appar
express
germin
center
b
cell
peyer
patch
age
young
mice
nongerminalcent
peanut
agglutinin
low
b
cell
display
compar
phenotyp
frequenc
old
young
mice
human
nasal
immun
influenza
vaccin
elicit
local
secretori
iga
respons
approxim
vaccin
age
approxim
year
averag
show
mucos
b
cell
antibodi
respons
basic
oper
age
human
germin
center
reaction
complex
process
b
cell
select
highaffin
bind
antigen
germin
center
thu
play
key
role
success
humor
immun
respons
besid
b
cell
cell
factor
integr
part
germin
center
age
mice
human
germin
center
impair
less
frequent
gener
germin
center
abundantli
detect
children
infant
lymph
node
fewer
seen
adult
number
germin
center
strongli
reduc
sometim
undetect
age
individu
age
year
especi
mesenter
cervic
lymph
node
normal
expos
antigen
stimul
analyz
paracort
medullar
area
within
lymph
node
show
slight
gradual
reduct
advanc
age
lymph
node
rather
infrequ
antigen
stimul
ie
peripher
cubit
axillari
poplit
lymph
node
display
agedepend
replac
lymphat
parenchyma
fat
lipomat
atrophi
histolog
analys
inguin
cervic
axillar
human
lymph
node
show
differ
number
size
follicl
rel
b
cell
count
includ
igm
igg
b
cell
children
adolesc
year
age
compar
individu
age
year
howev
clonal
cell
expans
addit
consid
germin
center
area
bigger
relat
mantl
zone
total
especi
igmexpress
cell
frequent
tissu
contain
clonal
cell
expans
compar
sampl
without
clonal
cell
expans
young
individu
sampl
age
donor
differ
observ
mous
germin
center
number
size
clearli
reduc
age
wherea
kinet
germin
center
dissoci
unaffect
b
cell
prolifer
appear
decreas
overal
age
individu
characterist
sustain
activationinduc
b
cell
prolifer
analyz
defect
b
cell
prolifer
suggest
contribut
immunosenesc
exampl
lipopolysaccharidestimul
splenic
b
cell
old
mice
prolifer
less
within
h
compar
young
anim
wherea
differ
express
activationinduc
express
observ
howev
impair
interact
lead
failur
cellb
cell
interact
discuss
sourc
immunosenesc
csr
shm
integr
process
affin
matur
b
cell
depend
express
activationinduc
cytidin
deaminas
aid
aid
express
affect
reduc
level
protein
encod
subject
agedepend
regul
murin
splenic
b
cell
old
mice
express
less
agerel
reduct
mrna
stabil
describ
impair
csr
detect
murin
b
cell
stimul
b
cell
activ
factor
vitro
similarli
human
peripher
blood
b
cell
age
individu
express
fewer
transcript
lower
aid
protein
level
reduc
csr
observ
shm
impair
b
cell
respons
either
b
cell
cell
origin
age
donor
transfer
scid
mice
immun
respons
nitrophenol
np
ig
v
h
hypermut
could
detect
old
mice
immun
wherea
select
antigen
appear
oper
mice
level
competit
nonmut
b
cell
clone
differ
also
hypothes
shm
select
impair
age
individu
nonimmun
mice
antibodi
origin
plasma
cell
carri
mutat
ig
rearrang
accumul
age
blood
serum
indic
accumul
mutat
plasma
cell
compart
accumul
partli
independ
csr
abrog
mice
kept
germfre
condit
absenc
bd
cell
receptor
analysi
human
peripher
cord
blood
b
cell
express
v
h
donor
show
similarli
reduc
mutat
frequenc
incid
mutat
v
h
rearrang
cord
blood
age
donor
blood
compar
normal
adult
blood
reflect
impair
affin
matur
earli
late
life
type
locat
base
substitut
differ
young
old
sampl
rs
ratio
higher
cdr
heavi
chain
region
old
sampl
indic
accumul
select
b
cell
igm
b
cell
v
h
famili
analyz
signific
alter
detect
mutat
frequenc
frequenc
mutat
sequenc
length
wherea
v
h
igg
sequenc
show
signific
increas
mutat
frequenc
mutat
frequenc
rs
ratio
found
neg
affect
age
human
v
k
rearrang
peripher
blood
agerel
chang
mostli
defect
note
germin
center
regard
helper
cell
follicular
dendrit
cell
fdc
essenti
compon
regular
germin
center
b
cell
respons
cell
exhibit
agerel
function
configur
chang
importantli
cell
age
individu
exhibit
impair
antigen
respons
prolifer
vivo
vitro
like
contribut
significantli
reduc
helper
function
thu
neg
affect
b
cell
respons
differenti
end
role
express
discuss
number
b
cell
express
found
margin
reduc
age
individu
blood
reflect
overal
reduct
total
b
cell
age
human
peripher
cell
composit
skew
toward
memori
phenotyp
advanc
age
similarli
observ
b
cell
adopt
transfer
studi
age
versu
young
cell
identifi
old
age
cell
major
origin
reduc
germin
center
format
antigenspecif
b
cell
humor
igg
respons
young
host
wherea
differ
b
cell
respons
note
young
cell
transfer
age
host
studi
analyz
contribut
age
cell
versu
age
b
cell
immun
respons
np
lymphocytereconstitut
scid
mice
shown
v
h
gene
repertoir
depend
mainli
age
donat
cell
rather
age
b
cell
engag
age
cell
led
express
ig
famili
express
young
cell
transfer
success
germin
center
reaction
depend
presenc
fdc
retain
immun
complex
may
present
b
cell
age
mice
impair
fdc
network
observ
retain
fewer
immun
complex
associ
reduc
number
size
germin
center
reduc
memori
b
cell
output
function
fdc
impair
appear
caus
reduc
express
fcg
receptor
ii
slight
reduct
complement
receptor
complement
receptor
express
well
reduc
presenc
absenc
immunecomplexcontain
vesicl
iccosom
within
fdc
express
indic
capabl
fdc
trap
immun
complex
also
strongli
reduc
age
mice
lymph
node
age
young
mice
tingibl
bodi
macrophag
yet
unclear
role
germin
center
reaction
found
absent
immun
respons
protein
antigen
radiolabel
antigen
use
analyz
antigen
retent
young
versu
old
mice
capabl
trap
retain
antigen
lymphoid
tissu
becam
detect
week
birth
persist
throughout
life
old
anim
antigen
transloc
lymphoid
follicl
remain
subcapsular
sinu
adjac
superfici
cortex
summari
defect
antigen
present
appear
constitut
sourc
b
cell
respons
impair
independ
intrins
cell
b
cell
defect
vast
major
studi
review
document
impair
b
cell
respons
age
mice
less
specif
b
cell
plasma
cell
gener
fewer
germin
center
result
antibodi
less
divers
repertoir
lower
avid
lower
protect
agerel
reduct
total
immunizationinduc
antigenspecif
bcellcontain
germin
center
number
observ
age
month
versu
young
month
mice
old
mice
compar
young
mice
fewer
npspecif
igg
plasma
cell
gener
spleen
immun
npchicken
gglobulin
number
drop
lower
level
mainten
phase
primari
respons
old
mice
plasma
cell
fail
establish
effici
bm
young
mice
upon
booster
immun
old
mice
also
gener
fewer
plasma
cell
spleen
bm
young
mice
signific
increas
antibodysecret
cell
number
compar
primari
respons
specif
serum
titer
also
gener
tenfold
lower
level
age
mice
remain
impair
also
secondari
vaccin
tenfold
greater
reduct
old
mice
compar
young
mice
v
h
b
cell
indic
antigenspecif
b
cell
analyz
reduc
accumul
somat
mutat
age
mice
observ
old
mice
fail
select
plasma
cell
higher
mutat
bm
consist
spleen
age
mice
harbor
antigenspecif
lowaffin
igm
plasma
cell
fewer
classswitch
plasma
cell
bm
contain
decreas
number
highand
lowaffin
plasma
cell
old
mice
compar
young
mice
reconstitut
old
mice
splenocyt
young
mice
led
restor
young
plasma
cell
respons
pattern
spleen
bm
reflect
reduc
capac
bm
recruit
maintain
plasma
cell
age
mice
produc
less
frequent
splenic
foci
contain
specif
b
cell
within
fewer
specif
b
cell
less
observ
immun
keyhol
limpet
hemocyaninphosphorylcholin
pc
reflect
oper
diminish
antigenspecif
b
cell
respons
old
anim
old
mice
util
atyp
ig
gene
plasma
cell
gener
immun
respons
pc
streptococcu
pneumonia
vaccin
trinitrophenol
antibodi
appear
less
protect
demonstr
loss
immun
protect
pneumococc
infect
mice
pcspecif
antibodi
gener
old
mice
inject
contrast
result
vaccin
hapten
b
cell
respons
influenza
viru
vaccin
show
agerel
declin
term
specif
b
cell
gener
repertoir
divers
primari
humor
b
cell
respons
tetanu
toxoid
less
effect
approxim
mice
young
mice
accompani
diminish
germin
center
count
size
reduc
lymphoid
plasma
cell
turnov
respons
antigen
within
poplit
lymph
node
age
mice
gener
reduc
number
splenic
plasma
cell
respond
anoth
tdepend
antigen
especi
number
igg
isotyp
high
avid
diminish
transfer
spleen
cell
old
anim
suppress
gener
regular
plasma
cell
compart
young
mice
upon
immun
gener
antiidiotyp
antibodi
rf
hypothes
regulatori
mechan
lead
reduc
humor
immun
respons
protect
number
antibodi
increas
advanc
age
serum
mice
human
see
later
appear
neg
influenc
respons
splenic
b
cell
syngen
genet
differ
donor
transfer
old
host
magnitud
antiidiotyp
antibodi
product
induc
tetanu
vaccin
associ
lower
tetanusspecif
antibodi
respons
total
serum
antibodi
level
stabl
adult
individu
show
modest
increas
age
mice
human
affect
igg
iga
rather
igm
antibodi
level
often
shown
increas
age
wherea
level
reduc
old
peopl
level
solubl
igd
shown
significantli
reduc
approxim
young
peopl
wherea
ige
level
remain
unchang
result
differ
detail
eg
age
signific
differ
antibodi
level
detect
magnitud
chang
although
determin
specif
old
individu
physic
vivo
halflif
human
murin
antibodi
determin
week
less
agerel
effect
antibodi
level
must
occur
level
plasma
cell
gener
persist
see
earlier
stromal
cell
may
finetun
antibodi
secret
involv
interact
stromalcellderiv
express
plasma
cell
henc
senesc
stromal
cell
might
impact
plasma
cell
homeostasi
antibodi
titer
demonstr
old
mice
impair
maintain
plasma
cell
bm
environ
affect
osteoporosi
enlarg
fat
deposit
older
age
antigenspecif
antibodi
titer
remain
detect
protect
level
age
year
viral
protein
antigen
wherea
replic
antigen
ie
viral
specif
antibodi
titer
halfliv
virtual
unchang
age
protein
antigen
tetanu
diphtheria
toxoid
declin
slowli
halflif
year
despit
regular
booster
immun
line
find
antirsv
igg
titer
undiminish
individu
year
age
compar
young
control
approxim
year
age
independ
frailti
wherea
among
us
citizen
older
year
fewer
protect
tetanusspecif
igg
titer
specificityrel
differ
might
aris
differ
natur
antigen
respect
heterogen
immun
activ
term
time
durat
antigen
affin
local
immun
respons
replic
sometim
persist
antigen
acquir
natur
infect
versu
nonrepl
degrad
antigen
often
appli
artifici
challeng
ie
vaccin
besid
amount
antibodi
avid
also
affect
age
upon
annual
repeat
influenza
vaccin
young
vaccine
develop
iga
antibodi
significantli
higher
avid
old
subject
similar
trend
observ
igg
antibodi
antibodi
antigen
besid
reduc
humor
respons
polysaccharid
vaccin
elderli
addit
exhibit
reduc
avid
specif
igg
compar
young
control
sera
old
vaccine
less
frequent
protect
mice
death
pneumococc
challeng
mice
transfer
experi
splenocyt
differ
age
anim
host
reveal
maximum
antibodi
avid
splenocyt
came
adult
mice
compar
lower
avid
cell
donat
young
old
anim
day
year
old
glycosyl
pattern
antibodi
drastic
effect
antibodi
function
appear
associ
autoimmun
total
human
serum
igg
show
agerel
kinet
rel
incid
agalctosyl
nlink
oligosaccharid
suggest
associ
rheumatoid
arthriti
minimum
year
higher
incid
birth
advanc
age
henc
ageassoci
glycosyl
pattern
could
also
contribut
develop
autoantibodi
perhap
autoimmun
age
individu
see
later
incid
antibodi
autolog
antigen
autoantibodi
product
human
increas
age
start
age
year
depend
type
autoantibodi
similar
phenomenon
describ
mice
among
centenarian
increas
strong
reduct
preval
autoantibodyposit
individu
observ
eg
antithyroglobulin
antigastr
pariet
cell
antibodi
pca
antibodi
rf
differ
note
organspecif
nonspecif
autoantibodi
regard
relat
frailti
test
individu
screen
european
individu
age
year
reveal
almost
express
least
one
autoantibodi
organspecif
nonspecif
autoantibodi
test
highest
preval
igm
rf
autoantibodi
reflect
autoimmun
diseas
organspecif
contrast
nonspecif
autoantibodi
rare
detect
individu
without
comorbid
disabl
least
one
organspecif
antibodi
detect
cohort
confirm
find
earlier
studi
old
individu
also
display
increas
usag
v
h
gene
famili
member
enrich
rearrang
potenti
lead
autoreact
antibodi
especi
v
h
found
associ
cold
agglutinin
diseas
individu
test
posit
autoantibodi
commonli
translat
autoimmun
diseas
nevertheless
autoantibodi
detect
year
onset
sle
leav
open
question
whether
autoantibodyposit
elderli
stage
benign
autoimmun
preced
overt
diseas
autoantibodi
may
aris
byproduct
vaccin
respons
mice
human
transient
increas
rf
product
observ
tetanu
influenza
booster
vaccin
normal
healthi
individu
rel
increas
underli
igg
reactiv
igm
b
cell
popul
correl
amount
tetanu
toxoid
specif
igg
measur
blood
serum
profound
vaccin
induc
igmrf
product
measur
blood
serum
role
b
cell
within
autoantibodi
product
appear
implic
periton
caviti
cell
shown
sourc
igm
rf
develop
chronic
lymphocyt
leukemia
occur
rather
old
age
often
show
phenotyp
howev
number
b
cell
becom
reduc
age
peripher
blood
although
old
individu
often
show
impair
immun
respons
benefit
vaccin
tdepend
tindepend
antigen
eg
reflect
reduc
rate
infect
vaccin
hospit
rate
number
outpati
visit
addit
combin
parenter
mucos
nasal
vaccin
provid
addit
protect
elderli
apart
vaccin
increas
effort
made
gener
recombin
monoclon
antibodi
antigenspecif
b
cell
isol
ex
vivo
immun
donor
neutral
pathogen
without
previou
vaccin
thu
circumv
agerel
limit
vaccin
develop
respons
clearanc
antibodybound
pathogen
depend
critic
complement
system
macrophag
also
affect
age
variou
techniqu
use
gener
neutral
antibodi
specif
influenza
hiv
sar
coronaviru
rsv
radic
attempt
reactiv
juvenil
immun
capabl
reconstitut
immun
system
autolog
stem
cell
immunoabl
autolog
stem
cell
transplant
asct
current
use
treat
sever
autoimmun
lymphoma
inde
lead
strong
clinic
improv
sle
multipl
sclerosi
besid
reactiv
thymic
activ
treatment
lead
erad
peripher
blood
b
cell
subsequ
establish
circul
b
cell
popul
mostli
approxim
consist
b
cell
year
asct
besid
proteasom
inhibit
eg
use
bortezomib
immunoabl
rabbit
antithymocyt
globulin
plu
asct
also
known
treatment
erad
plasma
cell
consequ
specif
antibodi
autoantibodi
product
immunoablationasct
treatment
target
pathogen
protect
immun
cell
thu
patient
carri
high
risk
suffer
sometim
fatal
infect
reactiv
capac
immun
system
immunoprotect
gener
earlier
influenc
lifestyl
b
cell
paramet
use
analyz
influenc
lifestyl
immun
system
improv
antigenspecif
serum
igg
splenic
b
cell
function
well
reduc
igg
catabol
demonstr
mice
allow
perform
voluntari
wheel
run
wherea
intens
exercis
associ
characterist
immunodepress
salivari
secretori
iga
level
significantli
increas
h
choir
sing
influenc
emot
state
mental
exercis
impact
nutrit
drug
consumpt
describ
alway
confirm
calor
restrict
associ
longer
life
span
mous
model
henc
lifestyl
factor
nutrit
eg
vitamin
diet
physic
mental
activ
could
repres
way
counteract
immunosenesc
apart
medic
intervent
